Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
microbiome
Biotech
Crestone’s antibiotic beats vancomycin at treating C. diff
Crestone's med stopped C. diff’s notorious comebacks: Just 4% of patients who received it had their infections return, compared to 23% for vancomycin.
Darren Incorvaia
Sep 5, 2024 3:11pm
Viral protein suppresses graft vs. host disease in mice
Jul 19, 2024 5:30am
New antibiotic kills off deadly bugs but spares the good ones
May 31, 2024 6:00am
MaaT posts 18-month data showing 'clear OS advantage' in aGvHD
Apr 15, 2024 7:05am
Clinical Microbiomics snaps up DNASense
Mar 1, 2024 9:00am
Genome & Co. posts data from phase 2 microbiome cancer trial
Jan 24, 2024 9:39am